Millennium Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Millennium Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311K	Hold	1,633	–	–	0.17%	105
2026 Q1	$276K	Buy	1,633 +2	+0.1%	+$342	0.17%	101
2025 Q4	$275K	Buy	1,631 +5	+0.3%	+$812	0.16%	111
2025 Q3	$235K	Hold	1,626	–	–	0.14%	121
2025 Q2	$206K	Hold	1,626	–	–	0.14%	119
2025 Q1	$208K	Hold	1,626	–	–	0.15%	109
2024 Q4	$215K	Hold	1,626	–	–	0.15%	106
2024 Q3	$237K	Hold	1,626	–	–	0.15%	108
2024 Q2	$223K	Hold	1,626	–	–	0.15%	109
2024 Q1	$223K	Buy	1,626 +50	+3%	+$6.83K	0.16%	108
2023 Q4	$214K	Buy	+1,576	New	+$192K	0.16%	112
2022 Q1	–	Sell	-2,126	Closed	-$324K	–	105
2021 Q4	$324K	Buy	+2,126	New	+$329K	0.25%	75

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Millennium Capital Advisors's IBB Position: Q2 2026 in Review

Millennium Capital Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,633 shares worth $311K. The position accounts for 0.17% of the portfolio, ranked #105.

Millennium Capital Advisors first reported a position in IBB in Q4 2021 and has held it in 12 quarters since. The position peaked at $324K in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Millennium Capital Advisors held 1,633 shares of iShares Biotechnology ETF worth $311K as of Q2 2026.
Millennium Capital Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.17% of Millennium Capital Advisors's portfolio in Q2 2026, its #105 holding.
Millennium Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 12 quarters since.
Millennium Capital Advisors's iShares Biotechnology ETF position peaked at $324K in Q4 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Millennium Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.